218 related articles for article (PubMed ID: 11279655)
1. CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform.
Foley R; Soamboonsrup P; Carter RF; Benger A; Meyer R; Walker I; Wan Y; Patterson W; Orzel A; Sunisloe L; Leber B; Neame PB
Am J Hematol; 2001 May; 67(1):34-41. PubMed ID: 11279655
[TBL] [Abstract][Full Text] [Related]
2. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.
Albano F; Mestice A; Pannunzio A; Lanza F; Martino B; Pastore D; Ferrara F; Carluccio P; Nobile F; Castoldi G; Liso V; Specchia G
Haematologica; 2006 Mar; 91(3):311-6. PubMed ID: 16531253
[TBL] [Abstract][Full Text] [Related]
3. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases.
Guglielmi C; Martelli MP; Diverio D; Fenu S; Vegna ML; Cantù-Rajnoldi A; Biondi A; Cocito MG; Del Vecchio L; Tabilio A; Avvisati G; Basso G; Lo Coco F
Br J Haematol; 1998 Sep; 102(4):1035-41. PubMed ID: 9734655
[TBL] [Abstract][Full Text] [Related]
5. CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint.
Biondi A; Luciano A; Bassan R; Mininni D; Specchia G; Lanzi E; Castagna S; Cantù-Rajnoldi A; Liso V; Masera G
Leukemia; 1995 Sep; 9(9):1461-6. PubMed ID: 7658712
[TBL] [Abstract][Full Text] [Related]
6. CD34 expression is associated with poor clinical outcome in patients with acute promyelocytic leukemia.
Lee JJ; Cho D; Chung IJ; Cho SH; Park KS; Park MR; Ryang DW; Kim HJ
Am J Hematol; 2003 Jul; 73(3):149-53. PubMed ID: 12827650
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
Lin P; Hao S; Medeiros LJ; Estey EH; Pierce SA; Wang X; Glassman AB; Bueso-Ramos C; Huh YO
Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].
Liang JY; Wu DP; Liu YJ; Ma QF; Xue YQ; Zhu MQ; Chen ZX
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):196-8. PubMed ID: 19615259
[TBL] [Abstract][Full Text] [Related]
10. Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants.
Sucić M; Zadro R; Burazer B; Labar B; Nemet D; Mrsić M; Aurer I; Mrsić S; Hitrec V; Boban D; Marković-Glamocak M; Batinić D; Uzarević B; Stavljenić-Rukavina A
J Hematother Stem Cell Res; 2002 Dec; 11(6):941-50. PubMed ID: 12590709
[TBL] [Abstract][Full Text] [Related]
11. CD2+ acute promyelocytic leukemia is associated with leukocytosis, variant morphology and poorer prognosis.
Kaito K; Katayama T; Masuoka H; Nishiwaki K; Sano K; Sekiguchi N; Hagino T; Kobayashi M
Clin Lab Haematol; 2005 Oct; 27(5):307-11. PubMed ID: 16178910
[TBL] [Abstract][Full Text] [Related]
12. Over-representation of bcr3 subtype of PML/RARalpha fusion gene in APL in Indian patients.
Sazawal S; Hasan SK; Dutta P; Kumar B; Kumar R; Kumar L; Choudhry VP; Saxena R
Ann Hematol; 2005 Nov; 84(12):781-4. PubMed ID: 16132910
[TBL] [Abstract][Full Text] [Related]
13. CD34 positive-microgranular variant of acute promyelocytic leukemia in a child.
Nargund AR; Patil GV; Raghuram CP; Venkataswamy E
Indian J Pathol Microbiol; 2012; 55(4):574-7. PubMed ID: 23455812
[TBL] [Abstract][Full Text] [Related]
14. [Association of CD34 cell surface antigen expression with cytomorphological characteristics of acute promyelocytic leukemia blasts and clinical characteristics of patients: one center experience].
Ostojić A; Pazur M; Siftar Z; Paro MM; Jelić-Puskarić B; Gredelj-Simec N; Radić-Kristo D; Kardum-Skelin I; Vrhovac R; Jaksić B
Acta Med Croatica; 2011 Sep; 65 Suppl 1():67-74. PubMed ID: 23126032
[TBL] [Abstract][Full Text] [Related]
15. Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping.
Gorczyca W
Pol J Pathol; 2012 Mar; 63(1):8-17. PubMed ID: 22535601
[TBL] [Abstract][Full Text] [Related]
16. [Relationship of immunophenotypic features with minimal residual disease detection and gene types in 221 cases of acute promyelocytic leukemia].
Wang YZ; Qin YZ; Jiang B; Zhu HH; Chang Y; Hao L; Li JL; Li LD; Chen SS; Huang XJ; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):271-6. PubMed ID: 19379549
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
[TBL] [Abstract][Full Text] [Related]
18. [The clinical and laboratory features of acute promyelocytic leukemia: an analysis of 513 cases].
Liang JY; Wu DP; Liu YJ; Ma QF; Gong JX; Zhu MQ; Xue YQ; Chen ZX
Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):389-92. PubMed ID: 18953948
[TBL] [Abstract][Full Text] [Related]
19. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
Paietta E; Goloubeva O; Neuberg D; Bennett JM; Gallagher R; Racevskis J; Dewald G; Wiernik PH; Tallman MS;
Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
[TBL] [Abstract][Full Text] [Related]
20. Impact of FLT3 mutations and promyelocytic leukaemia-breakpoint on clinical characteristics and prognosis in acute promyelocytic leukaemia.
Kuchenbauer F; Schoch C; Kern W; Hiddemann W; Haferlach T; Schnittger S
Br J Haematol; 2005 Jul; 130(2):196-202. PubMed ID: 16029447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]